| |
| |
|
| Insider
Information: |
Patel Sanj K |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
63,012 |
|
|
Indirect Shares
|
109,795 |
|
|
| Direct
Value |
$1,214,241 |
|
|
|
Indirect Value
|
$2,115,750 |
|
|
| Total
Shares |
172,807 |
|
|
| Total
Value |
$3,329,991 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
President & CEO, Direc... |
2015-06-22 |
0 |
2015-06-22 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
63,012 |
2024-04-08 |
109,795 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,569 |
54,703 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-09-04 |
4 |
OE |
$0.95 |
$52,072 |
D/D |
54,813 |
55,844 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-04-01 |
4 |
D |
$19.70 |
$37,489 |
D/D |
(1,903) |
57,095 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,482 |
58,998 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-04-08 |
4 |
D |
$17.90 |
$72,943 |
D/D |
(4,075) |
63,012 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-03-06 |
4 |
AS |
$21.00 |
$117,222 |
I/I |
(5,582) |
65,012 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,992 |
67,087 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2013-07-26 |
4 |
OE |
$1.70 |
$152,984 |
D/D |
52,190 |
70,425 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-03-04 |
4 |
AS |
$21.31 |
$273,834 |
I/I |
(12,742) |
70,594 |
0 |
% |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
72,000 |
73,031 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-10 |
4 |
AS |
$23.07 |
$26,231 |
I/I |
(1,137) |
83,336 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-09 |
4 |
AS |
$23.08 |
$543,973 |
I/I |
(23,569) |
84,473 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2021-02-08 |
4 |
AS |
$23.00 |
$104,144 |
I/I |
(4,528) |
108,042 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2020-10-12 |
4 |
AS |
$21.02 |
$2,087,917 |
I/I |
(99,330) |
112,570 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2020-10-12 |
4 |
OE |
$1.59 |
$239,613 |
D/D |
150,700 |
150,700 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2020-10-09 |
4 |
AS |
$21.00 |
$14,070 |
I/I |
(670) |
211,900 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2020-03-06 |
4 |
AS |
$20.00 |
$662,300 |
I/I |
(33,115) |
212,570 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
135,889 |
245,685 |
0 |
- |
|
93 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
